Joshua Bartch

Psilocybin is known as the active compound in so-called “magic mushrooms”, yet most psilocybin used in clinical trials today is synthesized in laboratories without the use of biological material. As psychedelics-assisted therapy gains momentum, investors need to understand the...

Mydecine Innovations Group (NEO:MYCO) (OTC: MYCOF) (FSE:0NFA) reported its financial results on Tuesday and provided a business update for the third quarter ended September 30. Q3 2021 Financial Highlights Net loss attributable to common stockholders was $4.5 million, or a basic and diluted loss...

Psychedelics and mycology company Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) is poised to wrap up the spin-out of its U.S. cannabis assets into a newly formed subsidiary. The Denver-based company announced Friday it has received shareholders' approval for the transaction at its...

Psychedelics and mycology company, Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE:0NFA), is seeking to increase shareholders value by spinning off its U.S. cannabis assets and its stake in U.S. cannabis projects into a newly formed subsidiary.  The Denver-based company intends...

Mydecine Innovations Group (OTC: MYCOF), a Denver-based psychedelics research company, announced its four lead novel drug candidates on Wednesday. The company plans to present the candidates at Pre-Investigational New Drug meetings with the FDA and Health Canada, a necessary step in obtaining...

Atai Inks Largest Fundraise In Sector History With $157M Series D Psychedelics and mental health company Atai Life Sciences has raised $157 million in venture capital. The Series D funding round is being touted as the psychedelics sector’s largest to date. Christian Angermayer, who founded...

Psychedelics and biopharma company Mydecine (CSE: MYCO) (PINK: MYCOF) recently announced the successful export of 20 kilograms of dried psilocybin mushrooms from a cultivation facility in Jamaica to a facility in Canada. A World’s First: According to the Denver-based company, this represents...

In recent years mushrooms left their dark, hidden habitats to jump into the spotlight of consumer markets. A hunger for natural foods and wellness products propelled consumers to explore the realm of fungi as a source of nutrition and wellness, as well as a means to achieving physical and mental...

Compass IPO Begins Trading on NASDAQ Following a NASDAQ filing earlier this month, UK-based psychedelics research company Compass Pathways began trading under the symbol CMPS on Friday. This is the first time a psychedelics company is listed on a major U.S. stock exchange. Some 7.5...

Psyched is a bi-monthly column covering the most important developments in the industry of medicinal psychedelics. We hope you follow us periodically as we report on the growth of this exciting new industry. Versión en Español en El Planteo. MindMed Inks Deal With Switzerland...